RCIPS current news
The focus on embracing appropriate health technology innovations has not been receiving enough attention. Most of the value propositions in health techs revolve around making healthcare affordable. However, by making technology low-cost does not automatically make if more affordable. There is a lot of innovation locked within such technology designs, however, the complexities of the healthcare industry are not considered.
Düsseldorf, Germany, November 18th, 2019. Nisonic AS, a startup co-founded by SINTEF and Cofounder in Norway, aims to make intracranial pressure (ICP) assessment as simple and easy as measuring body temperature. Nisonic is developing a novel method using properties of the optic nerve sheath to determine the patient’s ICP.
Sudesh Sivarasu believes that countries in the global south can and should solve their own problems rather than seeking solutions from elsewhere.
Imagine a settlement where people with different skills live close together and contribute to the community’s overall success: there are farmers who produce food, artisans who process the food, people who consume the food and others who remove waste. They cannot function in isolation relying on each other for survival. Together they are strong and thrive.
University of Cape Town (UCT) alumnus and former chairman and chief executive of Coca-Cola Neville Isdell has donated $1 242 160 (about R18 million) towards research into the discovery of new medicines for infectious diseases at the university’s Drug Discovery and Development Centre (H3D).
In a first for South Africa, a urine-recovery urinal system, developed in the University of Cape Town’s (UCT) Department of Civil Engineering, has been incorporated into the design of Growthpoint Properties’ new corporate headquarters for Exxaro in Centurion.
This year’s World IP Day campaign focused on sport and IP, exploring how innovation, creativity and IP rights encourage and protect innovations that support the development of sport and its enjoyment around the world.
UCT celebrated World IP Day with a seminar in collaboration with the Exercise Sports Science Medicine (ESSM) Department and the Sports Science Institute of South Africa (SISSA). The seminar featured talks from IP nad technology commercialization specialists an Inventor of IP applicable to sports.
A team of young University of Cape Town researchers attended a workshop on Translational Research, Health Innovation and Commercialization in Durban. The event targeted early-stage health and life science researchers and postgraduates from the participating institutions with the objective of introducing participants to the concepts and tools required to plan the translation of their research findings towards commercialisation, healthcare delivery and social impact.
The Route to Market (R2M) series is being developed using funding from the Department of Science and Technology’s National Intellectual Property Office (NIPMO). Each booklet focuses on a specific sector/product type and highlights the key steps and considerations in bringing such a product to market in that sector – with an emphasis on the local South African context, i.e. bringing research outputs into the marketplace and achieving “impact through innovation”.
The University of Cape Town’s (UCT) Department of Computer Science is set to enjoy a major boost with the naming of Dr Melissa Densmore, senior lecturer and Information and Communications Technologies for Development (ICT4D) staff member, as a recipient of the prestigious $500 000 National Academies Keck Futures Initiative (NAKFI) Challenge grant.
Over the past decade or so, there has been a massive shift in cancer research toward discovering more targeted therapeutic alternatives to chemotherapy and radiation. Subscribing to this approach, Professor Virna Leaner, head of the Division of Medical Biochemistry at UCT, and her group of researchers have dedicated their academic work to looking for novel cancer biomarkers that could serve as therapeutic targets.
The rising incidence of cancer in Africa coupled with the spiralling prices of leading therapies indicates that there is a great need for locally developed immune-oncology diagnostics and therapeutics. Following 20 years of work in the fields of medical biotechnology and immunotherapy in Germany, Professor Stefan Barth was recruited by the Department of Science and Technology/National Research Foundation’s South African Research Chair (SARChI) in 2015 to lead the Tier 1 Chair in Cancer Biotechnology at UCT.